Liraglutide: short-lived effect on gastric emptying-long lasting effects on body weight
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liraglutide: short-lived effect on gastric emptying-long lasting effects on body weight
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 14, Issue 6, Pages 531-538
Publisher
Wiley
Online
2012-01-07
DOI
10.1111/j.1463-1326.2012.01557.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients
- (2011) Anne Flint et al. ADVANCES IN THERAPY
- Characteristics of Patients With Chronic Unexplained Nausea and Vomiting and Normal Gastric Emptying
- (2011) Pankaj J. Pasricha et al. Clinical Gastroenterology and Hepatology
- Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans
- (2011) M. A. Nauck et al. DIABETES
- GLP-1 and energy balance: an integrated model of short-term and long-term control
- (2011) Jason G. Barrera et al. Nature Reviews Endocrinology
- Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents
- (2010) J. B. Buse et al. DIABETES CARE
- Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome
- (2010) Andreas Nygaard Madsen et al. JOURNAL OF ENDOCRINOLOGY
- Hepatic-Portal Vein Infusions of Glucagon-Like Peptide-1 Reduce Meal Size and Increase c-Fos Expression in the Nucleus Tractus Solitarii, Area Postrema and Central Nucleus of the Amygdala in Rats
- (2010) I. Baumgartner et al. JOURNAL OF NEUROENDOCRINOLOGY
- Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: Role of peripherally secreted and centrally produced peptides
- (2010) Niels Vrang et al. PROGRESS IN NEUROBIOLOGY
- Vagally mediated effects of glucagon-like peptide 1:in vitroandin vivogastric actions
- (2009) Gregory M. Holmes et al. JOURNAL OF PHYSIOLOGY-LONDON
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
- Arcuate Glucagon-Like Peptide 1 Receptors Regulate Glucose Homeostasis but Not Food Intake
- (2008) D. A. Sandoval et al. DIABETES
- Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide
- (2008) M. Horowitz et al. DIABETES OBESITY & METABOLISM
- Intrameal Hepatic Portal and Intraperitoneal Infusions of Glucagon-Like Peptide-1 Reduce Spontaneous Meal Size in the Rat via Different Mechanisms
- (2008) Elisabeth B. Rüttimann et al. ENDOCRINOLOGY
- Evidence that Intestinal Glucagon-Like Peptide-1 Plays a Physiological Role in Satiety
- (2008) Diana L. Williams et al. ENDOCRINOLOGY
- Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration
- (2008) Bronislava R. Gedulin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance
- (2008) Kirsten Lykkegaard et al. SCHIZOPHRENIA RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started